20-F/A XBRL

AMENDMENT NO. 2 TO FORM 20-F

Company: Clearmind Medicine Inc.
Filed: March 27, 2024
Period of Report: October 31, 2023
Accession Number: 0001213900-24-026622

View Document ↗ View on SEC.gov ↗